Search for: "Pfizer" Results 21 - 40 of 4,639
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Apr 2024, 11:30 pm by Yosi Yahoudai
  Pfizer did not recommend using after expiration because, “The potency beyond the expiration date cannot be assured and we don’t have information on the stability or the safety of the product after expiration. [read post]
8 Apr 2024, 12:15 am
., the company where he worked, by Pfizer Inc. to trade ahead of the news for his own enrichment. [read post]
5 Apr 2024, 5:19 am by jonathanturley
Clare Craig after she raised concerns about Pfizer trial documents. [read post]
28 Mar 2024, 11:52 am by Tom Kosakowski
 Braunsteiner has worked in recruiting for McKinsey since 2012 and previously worked in HR for Pfizer Deutschland GmbH. [read post]
26 Mar 2024, 6:00 am by Throneberry Law Group
Some of the companies named in the lawsuit include Johnson & Johnson, Chanel, Marky Kay, L’Oreal, Maybelline, and Pfizer. [read post]
17 Mar 2024, 2:00 am by Katharine Van Tassel
Miroslava Marinova (University of East London), Rethinking the legal test for excessive pricing: Insights from the Landmark UK CMA v Pfizer/Flynn Case and Its Legal Implications (2023): The legal treatment of excessive pricing in the pharmaceutical sector has been a... [read post]
12 Mar 2024, 9:13 pm by Patent Docs
Noonan -- Last week, the Federal Circuit handed down its opinion in Pfizer Inc. v. [read post]
8 Mar 2024, 12:30 pm by John Ross
Nonprofit sues Pfizer, alleging that its fellowship program for Black, Latino, and Native American undergraduates unlawfully excludes white and Asian American students, alleging that "Member A" and "Member B" are otherwise eligible for the fellowship. [read post]
7 Mar 2024, 5:42 pm by Howard Bashman
“Group suing over Pfizer diversity fellowship program loses US appeal”: Nate Raymond of Reuters has this report. [read post]
6 Mar 2024, 10:15 am by Steve Brachmann
Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Pfizer Inc. v. [read post]
6 Mar 2024, 10:15 am by Steve Brachmann
Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Pfizer Inc. v. [read post]
6 Mar 2024, 9:20 am by Legal Profession Prof
Lack of Article III standing doomed an attack on a diversity program of Phizer, per a decision of the United States Court of Appeals for the Second Circuit On September 15, 2022, Do No Harm filed suit against Pfizer, alleging... [read post]